This event occurred during plasma exchange therapy using plasmacure pe in china on (b)(6) 2020.Plasmcure pe is identical model to op-05w(a) marketed in us.Although the time elapsed after the start of treatment is unknown, the patient experienced sudden hypotension, palpitations, and chest tightness at 11:05.Plasma exchange therapy was discontinued, sodium chloride injection was administered intravenously, and vasopressor treatment of atropine sulfate hydrate, epinephrine, and dopamine hydrochloride were given.At 11:30, the symptoms were relieved and vital signs were stabilized.
|
The product of this event was not returned to the manufacturer and could not be analyzed; however, we investigated manufacturing and quality control records based on the lot number.According to the investigation, no potential for malfunction was found and no similar event has been reported with this lot number globally so far.The physician determined, this event as "serious injury" and the causal relationship between hypotension and the use of the medical device cannot be denied.We determined to report this incident since we also consider blood pressure decreased as "serious injury" and the causal relationship between hypotension and the use of the medical device cannot be denied.Hypotension is described as one of the adverse events in "e.Precautions" of ifu.We will continue to monitor the occurrence of similar events carefully.
|